Episode 11: Are we All Part of the GLP-1 Experiment?
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Episode 11: Are we All Part of the GLP-1 Experiment?
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
GLP-1 drugs like Ozempic and Wegovy have transformed conversations around weight loss and metabolic health — but are we witnessing a medical breakthrough or participating in a massive social experiment?
In this episode, we explore how these FDA-approved drugs moved from diabetes treatment to mainstream use for weight management, reshaping medicine, ethics, and culture along the way. We discuss how science identifies new uses for existing drugs, what we’ve learned from past off-label revolutions, and why GLP-1s may be testing not just our metabolism, but our trust in modern medicine itself.
Topics include:
- How GLP-1 receptor agonists work in the brain and body
- Why appetite, reward, and dopamine matter
- The balance between scientific discovery and real-world experimentation
- What this moment reveals about how we use (and market) medicine today
Available on all streaming platforms — just search “Gopu & Zane” or visit lybrandlab.org/jospod
Pas encore de commentaire